|
|
||
![]() |
|
|
|
|
Rewarding for you and us Defeat Diabetes Foundation Defeat Diabetes
Foundation 150 153rd Ave, Suite 300 Madeira Beach, FL 33708 |
Subcutaneous Insulin Lispro Safe and Effective for Diabetic KetoacidosisPosted: Wednesday, September 29, 2004
Dr. Guillermo E. Umpierrez, from Emory University in Atlanta, assessed the outcomes of 40 diabetic ketoacidosis patients who were randomized to receive subcutaneous insulin lispro or intravenous regular insulin. The patients' biochemical parameters on admission were similar in each group, the researchers point out. Moreover, the time needed to correct the biochemical abnormalities was comparable in each group--about 7 hours were required to correct the hyperglycemia and around 10.5 hours were needed to resolve the ketoacidosis. The groups were also similar in terms of length of hospital stay, hypoglycemia rate, and the amount of insulin used before ketoacidosis resolution. No deaths occurred in either group. The findings "raise interesting questions regarding the most cost-effective and labor-saving methods for treating a common disease in the hospital setting," Dr. Romana M. Haas and Dr. Andrew R. Hoffman, from Stanford University in California, note in a related editorial. "Since many cases of uncomplicated DKA are now being treated in emergency departments or overnight treatment units, it will be important to perform similar analyses in these settings. Source: Diabetes In Control.com: |
Join us on Facebook
Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.
![]() Send your unopened, unexpired test strips to:
|
|
|